EXTH-01. MODELING THE SAFETY OF TOPICAL AGENTS FOR SKIN TOXICITY ASSOCIATED WITH TUMOR TREATING FIELDS THERAPY IN GLIOBLASTOMA

Tumor Treating Fields are low intensity, intermediate frequency, alternating electric fields that are approved for the treatment of patients with glioblastoma (GBM). TTFields are applied continuously using a set of four transducer arrays placed on the skin. The main TTFields-related adverse event is...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Lacouture, Mario, Hershkovich, Hadas, Giladi, Moshe, Bomzon, Zeev, Kirson, Eilon, Weinberg, Uri, Plati, Yoram
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2018
Konular:
Abstracts
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216918/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.350
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller